Page last updated: 2024-10-25

cypermethrin and Cancer of Prostate

cypermethrin has been researched along with Cancer of Prostate in 1 studies

cypermethrin : A carboxylic ester resulting from the formal condensation between 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid and the alcoholic hydroxy group of hydroxy(3-phenoxyphenyl)acetonitrile.
zeta-cypermethrin : A diastereoisomeric mixture comprising the isomeric pair (1R)-cis-(alphaS)- and (1S)-trans-(alphaR)-cypermethrin together with the isomeric pair (1S)-cis-(alphaS)- and (1S)-trans-(alphaS)-cypermethrin where the ratio between the isomeric pairs lies in the range 45:55 to 55:45.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Q1
Zhou, JL1
Wang, H1
Ju, Q1
Ding, Z1
Zhou, XL1
Ge, X1
Shi, QM1
Pan, C1
Zhang, JP1
Zhang, MR1
Yu, HM1
Xu, LC1

Other Studies

1 other study available for cypermethrin and Cancer of Prostate

ArticleYear
Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation.
    Chemosphere, 2016, Volume: 158

    Topics: Androgen Receptor Antagonists; Animals; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; Humans; I

2016